China has approved CSPC Pharma’s RSV vaccine for clinical trials

China’s National Drug Administration has issued a release authorization to pharmaceutical group CSPC The drugmaker said it will begin clinical trials of a respiratory syncytial virus (RSV) vaccine in humans.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM